Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists set to develop animal-free model of human airways
It is hoped the project will prevent experiements on or with animals.
Model could prevent animal tests for toxicity of e-cigarettes

Scientists at Aston University are developing an animal-free model of the human airways, to be used for testing the toxicity of e-cigarettes.

It is hoped that the project, announced ahead of World No Tobacco Day (31 May), will prevent experiments on or with animals, as questions are raised about the long-term effects of e-cigarettes.

In the USA, such experiments are already taking place, in which animals are exposed to vapours for weeks or months on end. After the experiment, the animals are usually killed so that their tissues can be analysed.

The UK does not currently use animals to test e-cigarettes. If a manufacturer wanted to register them as an aid to quit smoking, however, they would be required under new regulations to have them tested as medicinal products, which may increase the chance of animal testing.

Jan Creamer, president of Animal Defenders International, which is funding the study, said: “Public outcry at smoking experiments led to them being ended, therefore the public, including those who vape, would be concerned to see animal tests for an alternative smoking product.

“We are excited to be funding the development of this innovative project which will save animals and provide accurate human-based data. It will also advance the way human cell lines can be maintained which could have far-reaching effects.”

Foetal calf serum (FCS) is the standard method used by researchers as the medium to grow human cell lines. However, this has raised ethical concerns owing to its collection method.

In this novel project, researchers will use multiple cell types submerged in medium without FCS. The cells will be tested and the results compared to previous data from cells grown with FCS.

The researchers will then test these cells under a “dynamic flow system” which more accurately mimics the environment in human airways. The model will then be used to see how the cells respond to e-cigarette exposure.

Project leader Dr Laura Leslie said: “The use of foetal calf serum to grow human cells, although currently standard practice, can present scientific challenges.

“By developing an entirely animal-free model, we hope to set the standard for a completely human-relevant method for investigating the effects of e-cigarettes on the human airways, an area where there is currently a lack of information.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.